-
Mashup Score: 0Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma | NEJM - 2 year(s) ago
Original Article from The New England Journal of Medicine — Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma | NEJM - 2 year(s) ago
Original Article from The New England Journal of Medicine — Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: journals.lww.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Impressive 4 year OS w/ Durvalumab in pts w/ #StageIII #NSCLC post CRT as reported by @finn_corinne @JTOonline We recently summarized current trials in this space in our review article led by star fellow @LovaSunMD @PennMDForum @PennCancer #LCSM 👉https://t.co/Z68YFHGZq8 https://t.co/Noqa0e7gWe https://t.co/NRikRij3Bt
-
-
Mashup Score: 0Medical Oncologists’ Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer - 4 year(s) ago
This article reports medical oncologists’ perspectives on the results of the IDEA Collaboration and assesses the real‐world update of this data.
Source: The OncologistCategories: Hem/Onc News and JournalsTweet
Overall Survival with #Brentuximab #Vedotin in Stage III or IV #HodgkinsLymphoma "Patients who received A+AVD... had a survival advantage over those who received ABVD"👇 https://t.co/uQyZeVrvNf @DrDavidStraus @KLFenton #StageIII #StageIV https://t.co/habp71d9UI